| Ytd | 52.64% | |
| 1y | 29.16% |
| Open | 39.00 | Prev Close | 38.40 | Low | 37.42 | High | 39.87 | Mkt Cap | 1.88B |
| Vol | 268.13K | Avg Vol | 457.12K | EPS | 0.83 | P/E | 45.63 | Forward P/E | 10.41 |
| Beta | 1.03 | Short Ratio | 7.56 | Inst. Own | 66.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 37.05 | 200-d Avg | 33.09 | 1yr Est | 51.67 |
NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
On October 09, 2026, Astrana Health Inc (ASTH) shares rose 4.7% to a current price of $37.55, within
ALHAMBRA, Calif., Oct. 9, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with it
Astrana Health, Inc. (ASTH) has an impressive earnings surprise history and currently possesses the
NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
Astrana Health, Inc. (NASDAQ: ASTH - Get Free Report) has received an average rating of "Moderate Bu
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
Astrana Health (NASDAQ: ASTH - Get Free Report) and Tenet Healthcare (NYSE: THC - Get Free Report) a
NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inve
LOS ANGELES--(BUSINESS WIRE)---- $ASTH--ASTH Investors Have Opportunity to Join Astrana Health, Inc.
SAN FRANCISCO--(BUSINESS WIRE)--AWKO Law LLP is investigating a data breach that led to unauthorized
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investor
Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.8
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inve
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C.
Oppenheimer analyst Michael Wiederhorn initiates coverage on Astrana Health (NASDAQ:ASTH) with a
Astrana Health is rated a buy, trading at a 46% discount to peers despite sector-wide reserve releas
Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and r
Barclays analyst Andrew Mok maintains Astrana Health (NASDAQ:ASTH) with a Overweight and raises t
Astrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript
Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.4 per share, beating the Zacks Co
Astrana Health NASDAQ: ASTH reported second-quarter 2026 revenue of $973 million, up 49% from a year
Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.8
Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.40 per share which beat the analyst c
Company to Host Conference Call on Thursday, August 6, 2026, at 2:30 p.m. PT/5:30 p.m.
On July 31, 2026, Astrana Health Inc (ASTH) shares fell 3.0% to a current price of $35.52. The stock
TD Cowen analyst Ryan Langston maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the p
BTIG analyst David Joyce maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price t
Barclays analyst Andrew Mok upgrades Astrana Health (NASDAQ:ASTH) from Equal-Weight to Overweight
Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and r
TD Cowen analyst Ryan Langston maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the p
Expands access to Astrana's Medicare ACO platform, powered by a unified AI-powered platform desi
Barclays analyst Andrew Mok maintains Astrana Health (NASDAQ:ASTH) with a Equal-Weight and raises
Wall Street analysts changed outlook on top names. Includes upgrades/downgrades. Check analyst rati
BTIG analyst David Larsen maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price
Needham analyst Matthew Shea maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the pri
Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.8
Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.29 per share which missed the analyst
Baird analyst Michael Ha maintains Astrana Health (NASDAQ:ASTH) with a Outperform and raises the
Medicare Advantage stocks surge as CMS finalizes 2027 rates. Read about the 2.48% base rate hike and
Dow Jones down 0.46% amid Iran-U.S. conflict, NASDAQ down 0.22% and S&P 500 down 0.39%. Energy s
U.S. stock market lower on Monday, with Dow Jones down 150 points. Astrana Health Inc (ASTH) shares
Astrana Health shares fell 22% after CMS proposed modest Medicare Advantage growth, but analyst says